Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

14.30

+0.78 (5.77%)

At close: Jan 16, 2026, 4:00 PM EST

14.40

+0.10 (0.72%)

After-hours: Jan 16, 2026, 7:52 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Relyvrio (Sodium Phenylbutyrate and Taurursodiol)	87.37M	Log In	Log In	Log In	Log In	Upgrade
Relyvrio (Sodium Phenylbutyrate and Taurursodiol) Growth	-77.06%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	87.37M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-77.06%	Log In	Log In	Log In	Log In	Upgrade